The State Of Cardiac Technology: The Path To Total Cardiac Intelligence
Published Date: 10.28.2025
Unlocking the Multi-Billion-Dollar Cardiac Intelligence Race
Cardiac diagnostics have reached a historic inflection point. The tools that once lived exclusively inside hospitals are moving into everyday life, transforming how heart disease is detected, managed, and prevented. The connected medical devices market – valued at $66 billion in 2024 and projected to reach $133 billion by 2029 (15% CAGR) – is expanding rapidly as clinical-grade monitoring merges with consumer technology. Yet despite this growth, a fundamental diagnostic gap persists: most cardiac events begin outside medical facilities, while the tools capable of detecting life-threatening ischemia remain confined to hospital walls.
The purpose of this analysis is to examine the technological and clinical landscape of electrocardiography (ECG) systems – consumer wearables, ambulatory monitors, and traditional 12-lead platforms – to understand how innovations in mobility, sensor fidelity, and data interpretation could close that diagnostic gap.
MDB Capital is a wholly-owned subsidiary of MDB Capital Holdings (Nasdaq: MDBH) and a broker-dealer registered with the U.S. Securities and Exchange Commission, a member of FINRA and a member of SIPC. Securities trading, account management, and investment banking services are offered by MDB Capital.
PatentVest, Inc. is a wholly owned subsidiary of MDB Capital Holdings and an affiliated company of MDB Capital.
All patent portfolio data and analysis in this report are based on publicly available information as of October 2025, sourced through PatentVest, our proprietary global patent database. While every effort has been made to ensure accuracy and completeness, the findings may not reflect unpublished, pending, or confidential filings. Companies may hold additional IP assets that are not yet publicly disclosed. This report should be considered a snapshot, not a definitive account, of current IP positions.
Information in this message from employees of MDB Capital or an affiliated company is based upon information that is believed to be reliable. However, neither MDB Capital nor its affiliates warrant its completeness, accuracy or adequacy.
